Search

everythinglearnresearchcommunity

for

Search:↓

Hair growth dysfunction involves various conditions with limited treatment options.

Telogen effluvium is a reversible hair loss condition that requires a detailed diagnosis and often resolves on its own.

Hair loss can happen after a fever caused by Rickettsia conorii infection.

Hair loss from telogen effluvium can cause mental health issues and lower life quality, needing both medical and emotional support.

COVID-19 infection may cause hair loss a few months after recovery.

COVID-19 may trigger sudden temporary hair loss.

The document concludes that we need more research to understand Telogen Effluvium and find effective treatments.

Critically ill patients may experience temporary hair loss after a fever.

A systematic approach is crucial for managing hair loss in women.

Systemic diseases can cause hair loss, which is often reversible with treatment.

The document explains different hair and scalp conditions, including common hair loss after pregnancy or illness, drug-induced hair loss, hereditary excessive hair growth, patterned baldness, autoimmune hair loss, and permanent loss due to skin disease, with generally limited treatment options.

New understanding and treatments for hair loss are improving, but more research is needed.

Weight loss can cause temporary hair loss, especially in women and older adults.

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.

Dengue fever can cause a temporary type of hair loss called telogen effluvium.

A woman experienced temporary hair loss after jaw surgery due to the stress of the operation.

Telogen effluvium is a common hair loss condition where many hairs enter the resting phase, often not noticeable until significant loss occurs, and treatment focuses on the underlying cause.

Severe COVID-19 may cause hair loss, and doctors recommend supplements and topical treatments to manage it.

COVID-19 infection may cause significant hair loss, but full hair recovery is likely without special treatment.

No effective treatment for hair loss after childbirth was found, but it usually gets better on its own and some cosmetic methods might help.

Alfredo Rebora suggests a simpler classification for hair loss and a new test for easier diagnosis.

More research is needed to find a cure for hair loss after pregnancy.

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

Treating post-COVID hair loss leads to full recovery, while not treating it often results in ongoing symptoms.

Hair loss can happen after both mild and severe COVID-19, and areas with more COVID-19 cases may see more hair loss cases.

COVID-19 infection can significantly cause temporary hair loss.

Children, especially teenagers, can get severe SARS-CoV infection with symptoms similar to adults, but they typically recover well with supportive care.

The paper suggests improving diagnosis and treatment of telogen effluvium but does not recommend a new classification system.

Alopecia Areata has no guaranteed treatment for hair regrowth, but options like corticosteroids and minoxidil are used, with future research focusing on genetic and immune therapies.

The document concludes that correct diagnosis of alopecia types is crucial, scalp biopsies are important, and more research is needed.